RxDoctor Payments Data

Patricia Flynn

Pediatric Infectious Diseases · Memphis, TNNPI 1609879865

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $14,926 of the $14,926 with a category attached, or 100.0%. Merck accounts for 82.6% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2022 at $7,913 and has fallen 89.3% since, to $850 in 2024.

$14,926in general payments, 2019–2025

Across 9 payments — averaging $1658.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$12K
  • Viiv Healthcare Company$3K
$17,386,146in research payments, 2019–2025

Across 21 payments — averaging $827,912 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Viiv Healthcare Company$17.4M
  • Janssen Research & Development, LLC$23K

What the payments were for

  • Consulting fees$14,926100%

General payments by program year

19
20
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck8$12,326
Viiv Healthcare Company1$2,600

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,926 in reported general payments places this provider in the 80th percentile of 36 pediatric infectious diseases providers in Tennessee.

See all pediatric infectious diseases providers in Tennessee →

Other pediatric infectious diseases in Memphis

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →